Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2239

6 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292239)

Label (Lbl636292239)
Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 20 mg / 5 mg / 12.5 mg by Bryant Ranch Prepack. The label includes dosage strength, prescription status (Rx only), and package count of 90 tablets. Manufacturer details list Par Pharmaceutical, NY. Storage instructions and other product information are printed on the side.*
FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)
Chemical structure of olmesartan medoxomil, an active ingredient in the combination tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide.*
FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)
Chemical structure of olmesartan medoxomil, representing its molecular arrangement with atoms and bonds clearly depicted.*
FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)
Chemical structure of olmesartan medoxomil, an active ingredient in the medication olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide.*
FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)
A line graph depicting multiple data series over time, with a vertical axis ranging from 55 to 100 and several lines representing different treatment groups or conditions including Baseline, and various dosage combinations involving 40, 10, and hydrochlorothiazide (HCTZ) 25 and 75. The graph plots values for each group, showing trends and comparisons among the series.*
FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)
A line graph depicting mean ambulatory systolic blood pressure (mmHg) at various hours post dose for different treatments including Baseline, AML 10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25, and OM40/HCTZ25. The x-axis represents hours post dose from 0 to 24, and the y-axis shows systolic BP ranging from 105 to 160 mmHg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.